Acadia (+21%): Q4 Revenue Beat Forces Violent Squeeze

Acadia Healthcare, a major operator of behavioral health facilities, experienced a violent 21% upside move on extreme volume. The catalyst was a Q4 earnings report that beat revenue expectations, coupled with strong Q1 guidance. This positive data ignited a squeeze in a heavily shorted stock that has been underperforming for months. But with full-year guidance disappointing the street, is this a sustainable turn or just a painful short cover?

The fundamental driver was Acadia’s Q4 2025 earnings release on the morning of 2/25/2026. The company reported adjusted EPS of $0.07, more than doubling the consensus estimate of $0.03. Even more critically, Q4 revenue came in at $821.5 million, a 6.1% YoY increase that surpassed the average analyst estimate of ~$800 million. This revenue beat, driven by a 3.1% increase in same-facility patient days, was the core surprise.

• Q4 Adj. EPS: $0.07 vs. $0.03 consensus estimate.
• Q4 Revenue: $821.5M vs. $800.1M consensus estimate.
• Q1 ’26 Guidance (Rev): $820M-$830M vs. $799.5M consensus estimate.

Trade Mechanics & Money Flow

Trade Mechanics: What Happened?

The move was defined by a technical breakout on massive volume. The stock closed at $20.84, exploding from the previous day’s close of $17.17. This price is trading at 1.8x its 52-week low (~$11.68) but is still less than half of its 52-week high (~$45.13). The action is typical of a short squeeze, where a positive catalyst forces short-sellers to buy back shares en masse, amplifying the upward momentum in a stock with previously bearish sentiment.

• Price Truth: Closing price of $20.84.
• 52-Week Range context: Well off highs of ~$45 but now ~80% above lows.
• Structure: A classic pain trade for shorts after a period of intense selling.

How Is The Money Flowing?

The footprint appears to be a mix of institutional re-entry and a significant short squeeze. The aggressive, high-volume buying off the earnings news suggests fundamental investors stepping in on the revenue surprise. However, the speed and magnitude of the rally point to forced covering from a crowded short base. The key battleground was the psychological $20 level, which the stock decisively broke through.

• Key Level: ~$20.00 was cleared with conviction.
• Player Mix: Institutions buying the fundamental beat, shorts forced to cover.
• Next Resistance: Watch for potential resistance near the $22-$24 zone from mid-2025.

Understanding trade mechanics, money flow, and price behavior can give you and edge. See more.

What Next?

FADE. While the Q4 revenue beat and strong Q1 guidance provided the spark, the full-year 2026 EPS guidance of $1.30-$1.55 was a significant miss against the consensus of ~$1.75. This suggests underlying profitability challenges remain. The 21% move was more of a technical repricing and a painful short squeeze than a fundamental re-rating of the long-term story. The next level to watch is the ~$18.50 level, the 200-day moving average mentioned in filings, as a potential support test if the post-earnings euphoria subsides.

That’s it for now, but so much more goes into evaluating a stock from long-term investment perspective. We make it easy with our Investment Highlights

Not comfortable with ACHC stock? Consider PORTFOLIOS instead.

Portfolios Are The Smarter Way To Invest

Individual stocks can soar or tank but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside and mitigate the downside associated with any individual stock.

Why settle for average market returns? The Trefis High Quality (HQ) Portfolio invests in a diverse group of 30 stocks that have collectively delivered stronger upside with reduced volatility compared to the broader indices. Discover the methodology behind these smoother, higher returns by checking the HQ Portfolio performance data.